Hemanext
Mike McNamara serves as the Chief Markets Officer, Investor, and Advisor to the Board of Directors at Hemanext since March 2023, where responsibilities include advising on strategic initiatives and capital raising, successfully raising over $180 million. Additionally, McNamara holds the position of Chief Markets Officer and Investor at KiActiv® and is the President and CEO of Ralston Capital Partners, LLC, an investment and advisory firm. Recent experience includes serving as Chief Capital Markets Officer at Castle Lanterra and Chief Investment Officer at The Goldenberg Group, focusing on real estate investment and capital markets. Previous roles encompass senior managing positions at Concord Hospitality Enterprises and Classic Group, as well as leadership in real estate finance at EYKL LLP and RBS. McNamara holds a Bachelor of Arts degree from Duke University.
This person is not in any teams
This person is not in any offices
Hemanext
1 followers
Hemanext is a medical technology company with headquarters and R&D Center of Excellence in Lexington MA, and manufacturing operations in Avon MA. Hemanext is committing its resources to the continuing effort of the transfusion medicine community to save lives and improve patient outcomes.